This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wahl, S. M. Articles by Janoff, E. N. Search for Related Content PubMed PubMed Citation Articles by Wahl, S. M. Articles by Janoff, E. N.

American Journal of Pathology, Vol 150, 1275-1284, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues

SM Wahl, P Worley, W Jin, TB McNeely, S Eisenberg, C Fasching, JM Orenstein and EN Janoff
Laboratory of Immunology, National Institute of Dental Research, Bethesda, MD 20892-4352, USA.

The rarity of oral transmission of human immunodeficiency virus (HIV)-1 by saliva suggests the absence of HIV-1 in the oral cavity and/or the presence of viral inhibitory molecules. We analyzed salivary gland tissues from 55 individuals with acquired immune deficiency syndrome (AIDS) for the presence of HIV-1 by in situ hybridization and detected the virus in more than 30% of these salivary glands. These data, together with previous demonstrations of HIV-1 in oral secretions, implicate a key role for an anti-viral molecule(s) in suppressing transmission. Thus, we focused on the characterization and localization of the endogenous antiviral molecule secretory leukocyte protease inhibitor (SLPI), which inhibits HIV-1 infection in vitro. Expression of SLPI transcripts was evident in submandibular, parotid, and minor salivary glands from both HIV-1-infected and seronegative subjects. Gene expression was reflected by similar levels of SLPI protein by immunohistochemical analysis in the tissues and by enzyme-linked immunosorbent assay in the saliva. However, although SLPI accumulated in acinar cells or ductal epithelium, HIV-1 transcripts did not, and these viral transcripts were identified only in mononuclear cells within the salivary gland stroma. By in situ hybridization, we found no evidence of productive HIV-1 infection of salivary gland epithelium. Thus, HIV-1 was frequently identified in salivary gland tissue, but the virus was found in interstitial mononuclear cells only and did not co- localize with SLPI. Once within the oral cavity, HIV-1 exposure to antiviral levels of SLPI may impede infection of additional target cells, contributing to the virtual absence of oral transmission of HIV- 1 by saliva. These studies emphasize the importance of innate, endogenous inhibitors of HIV-1, particularly SLPI, as effective inhibitors of HIV-1 transmission.

This article has been cited by other articles:

				M.C. Herzberg, A. Weinberg, and S.M. Wahl (C3) The Oral Epithelial Cell and First Encounters with HIV-1 Adv. Dent. Res., April 1, 2006; 19(1): 158 - 166. [Abstract] [Full Text] [PDF]

				N. K. Jana, L. R. Gray, and D. C. Shugars Human Immunodeficiency Virus Type 1 Stimulates the Expression and Production of Secretory Leukocyte Protease Inhibitor (SLPI) in Oral Epithelial Cells: a Role for SLPI in Innate Mucosal Immunity J. Virol., May 15, 2005; 79(10): 6432 - 6440. [Abstract] [Full Text] [PDF]

				K. L. Wood, P. Chaiyarit, R. B. Day, Y. Wang, C. T. Schnizlein-Bick, R. L. Gregory, and H. L. Twigg III Measurements of HIV Viral Loads From Different Levels of the Respiratory Tract Chest, August 1, 2003; 124(2): 536 - 542. [Abstract] [Full Text] [PDF]

				S. A. Freel, J. M. Williams, J. A. E. Nelson, L. L. Patton, S. A. Fiscus, R. Swanstrom, and D. C. Shugars Characterization of Human Immunodeficiency Virus Type 1 in Saliva and Blood Plasma by V3-Specific Heteroduplex Tracking Assay and Genotype Analyses J. Virol., May 15, 2001; 75(10): 4936 - 4940. [Abstract] [Full Text]

				K. Ikuta, S. Suzuki, H. Horikoshi, T. Mukai, and R. B. Luftig Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 725 - 745. [Abstract] [Full Text] [PDF]

				H. Hocini, P. Becquart, H. Bouhlal, H. Adle-Biassette, M. D. Kazatchkine, and L. Belec Secretory Leukocyte Protease Inhibitor Inhibits Infection of Monocytes and Lymphocytes with Human Immunodeficiency Virus Type 1 but Does Not Interfere with Transcytosis of Cell-Associated Virus across Tight Epithelial Barriers Clin. Vaccine Immunol., May 1, 2000; 7(3): 515 - 518. [Abstract] [Full Text] [PDF]

				S. Baron, J. Poast, and M. W. Cloyd Why Is HIV Rarely Transmitted by Oral Secretions?: Saliva Can Disrupt Orally Shed, Infected Leukocytes Arch Intern Med, February 8, 1999; 159(3): 303 - 310. [Abstract] [Full Text] [PDF]

				T. B. McNeely, D. C. Shugars, M. Rosendahl, C. Tucker, S. P. Eisenberg, and S. M. Wahl Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by Secretory Leukocyte Protease Inhibitor Occurs Prior to Viral Reverse Transcription Blood, August 1, 1997; 90(3): 1141 - 1149. [Abstract] [Full Text] [PDF]